September 26, 2019
Authored and Edited by Michelle G. Rice; Sydney R. Kestle; Elizabeth D. Ferrill
In Board of Regents of the University of Texas System v. Boston Scientific Corporation, No. 2018-1700 (Fed. Cir. Sept. 5, 2019), the Federal Circuit found it had jurisdiction to resolve University of Texas’s (UT) appeal from a district court’s venue transfer order, and held that state sovereignty principles did not grant UT the right to sue in an improper venue.
UT sued Boston Scientific Corp. (BSC) in the Western District of Texas for allegedly infringing its patents covering drug-releasing fibers. BSC is a Delaware corporation having a principal place of business in Massachusetts. Based on patent venue rules, BSC obtained an order transferring the case to Delaware. UT appealed from the transfer order on the basis of state sovereignty.
The Federal Circuit concluded it had jurisdiction to hear the appeal under the collateral order doctrine, an exception to the final judgment rule. On the merits, the Court rejected UT’s argument that state sovereignty allows a state to control where it litigates. The Court held state sovereignty applies only to suits “against” a state, and that it could not apply to UT because UT was the plaintiff. By suing in a federal court, UT subjected itself to federal court jurisdiction and the associated federal rules, including the governing venue rules.
Copyright © 2019 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
Webinar
Data and Market Exclusivity: An Update on China’s New Law and Comparisons to the US and Europe
November 19, 2026
Webinar
Seminar
U.S. Patent Litigation 2026: Key Developments, Strategic Trends, and Winning Before Trial
November 6, 2026
Taipei
Seminar
The Augmented Practice 2026: Balancing AI Opportunity, Governance, and Risk
November 5, 2026
San Francisco
Hybrid Conference
2026 Patent Law Institute: Critical Issues & Best Practices – New York
October 29, 2026
New York
Hybrid Conference
Intellectual Property Law Institute 2026 – California
October 19-20, 2026
San Francisco
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.